LYSX 📈 Multi Units France - Lyxor - Overview
Exchange: XETRA • Country: Germany • Currency: EUR • Type: Etf • ISIN: FR0007054358 • Eurozone Large-Cap Equity
LYSX: Eurozone Stocks, Blue-chip Companies, Currency Hedge
The Lyxor EURO STOXX 50 (DR) UCITS ETF is a UCITS compliant exchange traded fund that aims to track the benchmark index EURO STOXX 50 Net Return EUR, offsetting the impact of daily variations of the index local currency vs. the USD. The USD-hedged share class offers the simplicity of a daily currency hedge mechanism that is embedded in the investment product, representing an efficient solution to manage the foreign-exchange risk.The EURO STOXX 50 Net Return EUR is Europe's leading Blue-chip index for the Eurozone providing a Blue-chip representation of supersector leaders in the Eurozone from 50 stocks and over 12 Eurozone countries. It captures approximately 60% of the free float market capitalisation of the EURO STOXX Total Market Index (TMI), which in turn covers approximately 95% of the free float market capitalisation of the represented countries. More information on www.stoxx.com. ‣ Company URL: http://www.amundietf.com ‣ Domicile: France ‣ Index Name: Morningstar Dev Ezn TME NR EUR
Additional Sources for LYSX ETF
LYSX ETF Overview
Market Cap in USD | 2,551m |
Category | Eurozone Large-Cap Equity |
TER | 0.24% |
IPO / Inception | 2018-09-19 |
LYSX ETF Ratings
Growth 5y | 55.1% |
Fundamental | - |
Dividend | 21.6% |
Rel. Strength Industry | 147 |
Analysts | - |
Fair Price Momentum | 51.02 EUR |
Fair Price DCF | - |
LYSX Dividends
Dividend Yield 12m | 0.00% |
Yield on Cost 5y | % |
Annual Growth 5y | -100.00% |
Payout Consistency | 71.9% |
LYSX Growth Ratios
Growth Correlation 3m | -24.8% |
Growth Correlation 12m | 38.1% |
Growth Correlation 5y | 89.1% |
CAGR 5y | 7.74% |
CAGR/Mean DD 5y | 1.11 |
Sharpe Ratio 12m | 0.51 |
Alpha | -9.47 |
Beta | 0.75 |
Volatility | 10.85% |
Current Volume | 33.6k |
Average Volume 20d | 66.7k |
What is the price of LYSX stocks?
As of December 22, 2024, the stock is trading at EUR 52.82 with a total of 33,580 shares traded.
Over the past week, the price has changed by -1.65%, over one month by +2.84%, over three months by -0.95% and over the past year by +10.86%.
As of December 22, 2024, the stock is trading at EUR 52.82 with a total of 33,580 shares traded.
Over the past week, the price has changed by -1.65%, over one month by +2.84%, over three months by -0.95% and over the past year by +10.86%.
Is Multi Units France - Lyxor a good stock to buy?
Partly, yes. Based on ValueRay Analyses, Multi Units France - Lyxor (XETRA:LYSX) is currently (December 2024) ok to buy, but has to be watched. It has a Growth Technical Rating of 55.13 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of LYSX as of December 2024 is 51.02. This means that LYSX is currently overvalued and has a potential downside of -3.41%.
Partly, yes. Based on ValueRay Analyses, Multi Units France - Lyxor (XETRA:LYSX) is currently (December 2024) ok to buy, but has to be watched. It has a Growth Technical Rating of 55.13 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of LYSX as of December 2024 is 51.02. This means that LYSX is currently overvalued and has a potential downside of -3.41%.
Is LYSX a buy, sell or hold?
Multi Units France - Lyxor has no consensus analysts rating.
Multi Units France - Lyxor has no consensus analysts rating.
What are the forecast for LYSX stock price target?
According to ValueRays Forecast Model, LYSX Multi Units France - Lyxor will be worth about 56.3 in December 2025. The stock is currently trading at 52.82. This means that the stock has a potential upside of +6.55%.
According to ValueRays Forecast Model, LYSX Multi Units France - Lyxor will be worth about 56.3 in December 2025. The stock is currently trading at 52.82. This means that the stock has a potential upside of +6.55%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 56.3 | 6.6% |